Back to search

Article

STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol

2022-07-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19, presents major threats to individual and public health across countries, affecting over 1.5 million people in the UK alone. Evidence-based interventions are urgently required and an integrated care pathway (ICP) approach in pragmatic trials, which include investigations, treatments and rehabilitatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd17151d-63d8-5f0f-941b-0e3025f15011
DOI
10.1101/2022.07.21.22277893
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocolDOI 10.1101/2022.07.21.22277893
Select a neighboring publication to make it the new centre.